Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genasense PK in Advanced Melanoma with Hepatic Impairment
NCT00543205Phase 3Terminated
- Sponsor
- Genta Incorporated
- Start
- Aug 2005
- Primary completion
- May 2007
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
01
Overview
A Phase 3 trial of oblimersen in melanoma, sponsored by Genta Incorporated. Started Aug 2005; status: terminated.
02
Drugs
oblimersen
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00543205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543205.